                         SEQUENCE LISTING

<110>  UMBRA THERAPEUTICS INC.
       Barbe, Guillaume
       Saulnier, Mark
       Greenlee, William
       Ray, Soumya
 
<120>  COVALENT BINDING COMPOUNDS FOR THE TREATMENT OF DISEASE

<130>  20122-004WO1

<150>  US 63/157,412
<151>  2021-03-05

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Protein Recognition Moiety

<400>  1

Met Ile Arg Ser Phe Ser Glu Pro Phe Gly Arg Asp Leu Leu 
1               5                   10                  


<210>  2
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Protein Recognition Moiety

<400>  2

Arg Arg Gln Arg Ser Ala Pro 
1               5           


<210>  3
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Protein Recognition Moiety

<400>  3

Ser Ile Ser Arg 
1               


<210>  4
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Protein Recognition Moiety

<400>  4

Arg Thr Gln Ser Leu Ser Ala Leu 
1               5               


<210>  5
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Protein Recognition Moiety

<400>  5

Arg Ser Met Ser Glu Thr Gly Thr 
1               5               


<210>  6
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Protein Recognition Moiety

<400>  6

Thr Asn Pro Glu Ser Lys Val Phe Tyr Leu 
1               5                   10  


<210>  7
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Protein Recognition Moiety

<400>  7

Arg Gln Arg Ser Ala Pro 
1               5       


<210>  8
<211>  27
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Protein Recognition Moiety

<400>  8

Gly Gln Gln Asp Leu Met Ile Asn Asn Pro Leu Ser Gln Asp Glu Gly 
1               5                   10                  15      


Ser Leu Trp Asn Lys Phe Phe Gln Asp Lys Glu 
            20                  25          


<210>  9
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Protein Recognition Moiety

<400>  9

Val Glu Pro Gln Lys Phe Ala Glu Glu Leu Ile His Arg Leu Glu Ala 
1               5                   10                  15      


Val Gln 
        


<210>  10
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Protein Recognition Moiety


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa can be any naturally occurring amino acid

<400>  10

Xaa Phe Thr Xaa Ala Gln Xaa 
1               5           


<210>  11
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Protein Recognition Moiety

<400>  11

Tyr Ser Pro Thr Ser Pro Ser Tyr Ser Pro Thr Ser Pro Ser 
1               5                   10                  


